SIGA Clarifies European Regulatory Path for Lead Smallpox Anti-viral ST-246 (GlobeNewswire via Yahoo! Finance)

Posted on Thu, 12 Feb 2009 22:01:45 +0000 in Anti virus

NEW YORK, Jan. 13, 2009 -- SIGA Technologies, Inc. , a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, today announced it has received favorable written guidance from the European Medicines Authority about its proposal that its lead orthopox anti-viral drug, ST-246, should be evaluated using the Agency's procedures for the granting of a marketing ...

Original article: SIGA Clarifies European Regulatory Path for Lead Smallpox Anti-viral ST-246 (GlobeNewswire via Yahoo! Finance) by Copyright (c) 2004 Yahoo! Inc. All rights reserved. at Yahoo! News Search Results for free anti virus
Tags: